MI: Making a Difference
April 6, 2012
Less Intensive Hodgkin's Chemo Works Better
Fewer cycles of an intensive chemotherapy regimen for advanced Hodgkin's lymphoma improves outcomes and reduces toxicity, researchers found.
Treatment failure over 5 years actually occurred less often with six cycles of the dose-escalated regimen known as BEACOPP than with the usual eight cycles (89.3% versus 84.4%, 97.5% CI 0.5 to 9.3), according to Andreas Engert, MD, of the University Hospital of Cologne, Germany, and colleagues.